Evaluation of surgical resection in advanced ovarian, fallopian tube, and primary peritoneal cancer: laparoscopic assessment. A European Network of Gynaecological Oncology Trial (ENGOT) group survey

. 2020 Jun ; 30 (6) : 819-824. [epub] 20200430

Jazyk angličtina Země Spojené státy americké Médium print-electronic

Typ dokumentu časopisecké články, multicentrická studie

Perzistentní odkaz   https://www.medvik.cz/link/pmid32354792

OBJECTIVE: Laparoscopy is one of the diagnostic tools available for the complex clinical decision-making process in advanced ovarian, fallopian tube, and peritoneal carcinoma. This article presents the results of a survey conducted within the European Network of Gynaecological Oncology Trial (ENGOT) group aimed at reviewing the current patterns of practice at gynecologic oncology centers with regard to the evaluation of resection in advanced ovarian, fallopian tube, and peritoneal carcinoma. METHODS: A 24-item questionnaire was sent to the chair of the 20 cooperative groups that are currently part of the ENGOT group, and forwarded to the members within each group. RESULTS: A total of 142 questionnaires were returned. Only 39 respondents (27.5%) reported using some form of clinical (not operative) score for the evaluation of resection. The frequency of use of diagnostic laparoscopy to assess disease status and feasibility of resection was as follows: never, 21 centers (15%); only in select cases, 83 centers (58.5%); and routinely, 36 centers (25.4%). When laparoscopy was performed, 64% of users declared they made the decision to proceed with maximal effort cytoreductive surgery based on their personal/staff opinion, and 36% based on a laparoscopic score. To the question of whether laparoscopy should be considered the gold standard in the evaluation of resection, 71 respondents (50%) answered no, 66 respondents (46.5%) answered yes, whereas 5 respondents (3.5%) did not provide an answer. CONCLUSIONS: This study found that laparoscopy was routinely performed to assess feasibility of cytoreduction in only 25.4% of centers in Europe. However, it was commonly used to select patients and in a minority of centers it was never used . When laparoscopy was adopted, the treatment strategy was based on laparoscopic scores only in a minority of centers.

AGO Austria and Department of Obstetrics and Gynecology Medical University of Innsbruck Innsbruck Austria

Arbeitsgemeinschaft Gynäkologische Onkologie Group and Department of Gynecology and Gynecologic Oncology Kliniken Essen Mitte gGmbH Essen Germany

Belgium and Luxembourg Gynaecological Oncology Group and Department of Gynecology and Obstetrics University Hospitals Leuven Leuven Belgium

Central and Eastern European Gynecologic Oncology Group and Department of Obstetrics and Gynecology 1st Faculty of Medicine Charles University and General University Hospital Prague Czech Republic

Dutch Gynaecological Oncology Group and Department of Obstetrics and Gynecology Radboud University Medical Centre Nijmegen the Netherlands

Groupe des Investigateurs Nationaux pour l'Etude des Cancers de l'Ovaire gynécologiques et du sein and Department of Medical Oncology Hôpital Hôtel Dieu Université Paris Descartes Paris France

Grupo Español de Investigación en Cáncer de Ovario and Department of Medical Oncology Clínica Universidad de Navarra Madrid Spain

Israeli Society of Gynecologic Oncology and Department of Gynecologic Oncology Sheba Medical Center Sackler School of Medicine Tel Aviv University Tel Hashomer Tel Aviv Israel

Mario Negri Gynecologic Oncology Group and Department of Gynecologic Oncology Istituto Europeo di Oncologia Milan Italy

Multicentre Italian Trials in Ovarian cancer and gynecologic malignancies Group and Department of Gynecologic Oncology Surgery Istituto Nazionale Tumori IRCSS Fondazione G Pascale Naples Italy

National Cancer Research Institute and Department of Surgery and Cancer Imperial College London London United Kingdom

Nord Ostdeutsche Gesellschaft für Gynäkologische Onkologie and Department of Gynecologic Oncology Charité Comprehensive Cancer Center Berlin Berlin Germany

Polish Gynecologic Oncology Group and Department of Gynecological Oncology Poznan University of Medical Sciences Poznan Poland

Swiss Group for Clinical Cancer Research and Department of Gynecology University Hospital Zurich Zurich Switzerland

Turkish Society of Gynecologic Oncology and Department of Gynecologic Oncology Mugla Sitki Kocman University Education and Research Hospital Mugla Turkey

Ηellenic Cooperative Oncology Group and 2nd Department of Medical Oncology Agii Anargiri Cancer Hospital Athens Greece

Citace poskytuje Crossref.org

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...